Prothena to Participate in Jefferies Healthcare Conference
02 Junho 2022 - 5:05PM
Prothena to Participate in Jefferies Healthcare Conference
Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical
biotechnology company with a robust pipeline of investigational
therapeutics built on protein dysregulation expertise, today
announced that members of its senior management team will
participate in a fireside chat at the Jefferies Healthcare
Conference on Wednesday June 8, 2022 at 8:30 AM ET.
A live webcast of the fireside chat can be
accessed through the investor relations section of the Company's
website at www.prothena.com. Following the live presentation,
a replay of the webcast will be available on the Company's website
for at least 90 days following the presentation date.
About Prothena
Prothena Corporation plc is a late-stage
clinical biotechnology company with expertise in protein
dysregulation and a pipeline of investigational therapeutics with
the potential to change the course of devastating neurodegenerative
and rare peripheral amyloid diseases. Fueled by its deep scientific
expertise built over decades of research, Prothena is advancing a
pipeline of therapeutic candidates for a number of indications and
novel targets for which its ability to integrate scientific
insights around neurological dysfunction and the biology of
misfolded proteins can be leveraged. Prothena’s pipeline includes
both wholly-owned and partnered programs being developed for the
potential treatment of diseases including AL amyloidosis, ATTR
amyloidosis, Alzheimer’s disease, Parkinson’s disease and a number
of other neurodegenerative diseases. For more information, please
visit the Company’s website at www.prothena.com and
follow the Company on Twitter @ProthenaCorp.
Contacts:MediaEric Endicott,
Senior Vice President, Corporate Affairs650-448-3670,
media@prothena.com
InvestorsJennifer Zibuda, Director, Investor
Relations & Communications650-837-8535,
jennifer.zibuda@prothena.com
Prothena (LSE:0Y3M)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
Prothena (LSE:0Y3M)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024
Notícias em tempo-real sobre Prothena Corporation Plc da Bolsa de Valores de Londres bolsa de valores: 0 artigos recentes
Mais Notícias de